Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB)

131 filings reported holding YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2021.
Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26,145,321 shares of 45,101,565 outstanding shares and own 57.97% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4,448,610 shares), BlackRock Inc. (2,703,691 shares), Sofinnova Investments, Inc. (2,194,278 shares), VANGUARD GROUP INC (1,635,255 shares), FMR LLC (1,548,987 shares), STATE STREET CORP (1,389,511 shares), ALLIANCEBERNSTEIN L.P. (1,348,596 shares), Artisan Partners Limited Partnership (1,318,279 shares), First Light Asset Management, LLC (950,192 shares), and GOLDMAN SACHS GROUP INC (820,482 shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.